CXorf48 is a potential therapeutic target for achieving treatment-free remission in CML patients

M. Matsushita, K. Ozawa, T. Suzuki, M. Nakamura, N. Nakano, S. Kanchi, D. Ichikawa, E. Matsuki, M. Sakurai, D. Karigane, H. Kasahara, N. Tsukamoto, T. Shimizu, T. Mori, Hideaki Nakajima, S. Okamoto, Y. Kawakami, Y. Hattori

Research output: Contribution to journalArticlepeer-review

9 Citations (Scopus)

Fingerprint

Dive into the research topics of 'CXorf48 is a potential therapeutic target for achieving treatment-free remission in CML patients'. Together they form a unique fingerprint.

Medicine & Life Sciences